News
EBS
8.75
+3.55%
0.30
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
Barchart · 3d ago
Weekly Report: what happened at EBS last week (0930-1004)?
Weekly Report · 4d ago
Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario
Seeking Alpha · 10/04 13:48
Emergent BioSolutions Grants CFO Stock for Contributions
TipRanks · 10/04 11:47
What's Going On With Emergent BioSolutions Stock Wednesday?
Benzinga · 10/02 16:39
Emergent Biosolutions Secures Loan, Bolsters Growth Strategy
TipRanks · 10/02 12:28
Emergent BioSolutions closes $100M asset-backed loan facility
TipRanks · 10/02 11:40
Press Release: Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
Dow Jones · 10/02 11:30
'Newsom Signs Bill Pushing For Narcan In Workplace First Aid Kits' - LA Times
Benzinga · 09/30 14:12
Weekly Report: what happened at EBS last week (0923-0927)?
Weekly Report · 09/30 09:15
Amazon to provide opioid overdose drug in workplace
Seeking Alpha · 09/27 15:17
'Amazon to Stock Opioid Overdose Reversal Drug Narcan at Its Warehouses' -Wall Street Journal Report
Benzinga · 09/27 14:12
Amazon to stock Narcan opioid overdose reversal drug at warehouses, WSJ reports
TipRanks · 09/27 14:10
Emergent Bio gains after U.S. govt. order for smallpox therapy
Seeking Alpha · 09/26 18:36
Emergent BioSolutions Shares Rise on U.S. Smallpox-Treatment Order
Dow Jones · 09/26 18:07
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/26 16:31
Emergent BioSolutions announces execution of contract options valued at $67.4M
TipRanks · 09/26 12:20
Emergent BioSolutions Announces The Execution Of Contract Options Valued At $67.4M To Procure Additional TEMBEXA To Support National Preparedness Efforts
Benzinga · 09/26 12:08
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
Benzinga · 09/25 14:33
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
NASDAQ · 09/25 13:08
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.